Research desks at Lakshmishree and 4 other desks backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
Lakshmishree and 4 other registered desks issued 8 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a bullish bias — 8 buys against 0 sells — covering 5 stocks.
M&MFIN was flagged for a buy by Lakshmishree at ₹400.5, targeting ₹409.75 — a potential upside of +2.3%, with a stoploss at ₹390. The risk-to-reward ratio stands at 1:0.9.
PNGSREVA was flagged for a buy by Ndtv Profit at ₹1,156, targeting ₹1,375 — a potential upside of +18.9%, with a stoploss at ₹1,024. The risk-to-reward ratio stands at 1:1.7.
SUNPHARMA attracted 4 separate recommendations from registered analysts — Ndtv Profit issued a buy at ₹2,083 targeting ₹2,230 (stop ₹1,930); Zee Business issued a buy at ₹1,990 targeting ₹2,400; Cnbc Awaaz issued a buy at ₹1,990 targeting ₹2,150 (stop ₹2,120); Cnbc Awaaz issued a buy at ₹1,990.5 targeting ₹2,120.
Also covered: INDUSTOWER (₹396 → ₹420) via PLTechnicalResearch; PPLPHARMA (₹202 → ₹220.2) via Lakshmishree.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.